According to KOB 4, “University of New Mexico School of Medicine researchers have begun enrolling children in a clinical trial to test the safety and efficacy of the Moderna COVID-19 vaccine.”
The report notes that 60 New Mexico children ages 6-12 are eligible to enroll in the first phase of the clinical trial.
The report notes how “UNM is one of 88 sites, in the U.S. and Canada, participating in Moderna’s KidCOVE study.”
“UNM is in a unique position to include a larger proportion of Hispanic and Native American children in the study than sites located elsewhere in the country,” said Hengameh Raissy, PharmD, a Research Professor in Pediatrics and co-principal investigator on the study.
The report notes:
Children will receive either a placebo or the first dose of the Moderna vaccine when they enroll. Participants then return about a month later for their second shot,” the report notes
After the second shot, children and parents will return to UNM for follow-up testing in the subsequent months. Children will also have at least two visits with the research team after each injection.
Another study experimenting on even younger children aged two to six months old and six months to two years old will occur later this Fall. According to the report, the UNM team is awaiting the exact start date.